PEBC Evaluating Exam flashcards
PEBC Evaluating Exam · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Cardiac output formula
- Cardiac output equals heart rate multiplied by stroke volume. In a resting adult it averages about 5 litres per minute and rises during exercise or metabolic demand.
- Glomerular filtration rate
- GFR is the volume of plasma filtered by the kidneys per unit time. Normal is about 125 mL/min/1.73 m²; creatinine clearance approximates it but overestimates because creatinine is secreted.
- Insulin signalling mechanism
- Insulin binds a receptor tyrosine kinase and triggers GLUT4 translocation to the membrane of skeletal muscle and adipose cells, increasing glucose uptake and lowering blood glucose.
- Henderson-Hasselbalch bicarbonate equation
- pH = 6.1 + log([HCO3−]/(0.03 × PaCO2)). It describes the bicarbonate buffer system and is used to classify metabolic versus respiratory acid-base disorders.
- Anion gap calculation
- Anion gap = Na+ − (Cl− + HCO3−); normal is 8–12 mmol/L. It rises in ketoacidosis, lactic acidosis, renal failure and poisoning by methanol, ethylene glycol or salicylate.
- Immunoglobulin classes
- IgG crosses the placenta and dominates secondary responses; IgM appears first in primary responses; IgA is secreted in mucosal fluids; IgE mediates type I hypersensitivity; IgD sits on B cells.
- Adrenergic receptor effects
- Alpha-1 receptors cause vasoconstriction; beta-1 receptors increase heart rate and contractility; beta-2 receptors cause bronchodilation and vasodilation; alpha-2 receptors inhibit presynaptic norepinephrine release.
- Gram stain mechanism
- Gram-positive bacteria have thick peptidoglycan that retains crystal violet and stain purple. Gram-negative bacteria have thin peptidoglycan and an outer lipopolysaccharide membrane, so they lose dye and stain pink.
- Half-life equation
- t1/2 = 0.693 × Vd ÷ CL. It is the time for plasma concentration to fall by half during first-order elimination, and about 4–5 half-lives are needed to reach steady state.
- Volume of distribution
- Vd = amount of drug in the body ÷ plasma concentration. A large Vd indicates extensive distribution into tissues; Vd is used to calculate loading doses.
- Clearance at steady state
- For a continuous intravenous infusion at steady state, clearance = dose rate ÷ Css. Clearance is the volume of plasma cleared of drug per unit time and sets the maintenance dose.
- Oral bioavailability equation
- F = (AUC_oral × dose_IV) ÷ (AUC_IV × dose_oral). It is the fraction of an oral dose reaching systemic circulation; F equals 1 for intravenous dosing.
- Loading dose formula
- Loading dose = (Vd × target concentration) ÷ F. It rapidly raises drug concentration to the therapeutic range, while maintenance dosing replaces eliminated drug.
- Michaelis-Menten kinetics
- V = Vmax × C ÷ (Km + C). At concentrations well below Km elimination is first-order; well above Km it becomes zero-order, as with phenytoin or ethanol.
- Noyes-Whitney dissolution rate
- Dissolution rate = (D × A ÷ h) × (Cs − C). Rate increases with surface area, solubility and agitation; dissolution is often rate-limiting for poorly soluble oral drugs.
- Prodrug activation examples
- Enalapril is hydrolysed to enalaprilat; codeine is O-demethylated to morphine by CYP2D6; clopidogrel is activated by CYP2C19. Prodrugs can improve absorption or target activation.
- Warfarin INR targets
- Most atrial fibrillation and venous thromboembolism patients target INR 2.0–3.0. A mechanical mitral valve targets 2.5–3.5. Vitamin K reverses over-anticoagulation.
- Metformin contraindications
- Metformin is first-line for type 2 diabetes but is contraindicated when eGFR is below 30 mL/min/1.73 m². It is held during acute illness and iodinated contrast procedures.
- ACE inhibitor adverse effects
- ACE inhibitors cause cough from bradykinin accumulation, hyperkalemia, angioedema, hypotension and acute kidney injury. They are contraindicated in pregnancy and require potassium and creatinine monitoring.
- Statin myotoxicity
- Statins can cause myalgia and rarely rhabdomyolysis. Creatine kinase is checked if muscle symptoms occur. CYP3A4 inhibitors increase exposure to simvastatin and atorvastatin.
- Digoxin toxicity
- Digoxin has a narrow therapeutic index, with a heart failure target of 0.5–0.9 ng/mL. Toxicity causes nausea, confusion, visual changes and arrhythmias; hypokalemia and renal impairment increase risk.
- Acetaminophen antidote
- N-acetylcysteine is the antidote for acetaminophen overdose. It replenishes glutathione and is most effective within 8 hours; the Rumack–Matthew nomogram guides treatment decisions.
- Opioid overdose antidote
- Naloxone is a competitive opioid antagonist used for opioid overdose. It is shorter-acting than many opioids, so repeat doses or an infusion may be required while monitoring respirations.
- Aminoglycoside monitoring
- Aminoglycosides require peak and trough levels to balance efficacy and toxicity. They cause nephrotoxicity and ototoxicity. Extended-interval once-daily dosing is commonly used.
- Health Belief Model
- It predicts health behaviour from perceived susceptibility, severity, benefits and barriers, plus cues to action and self-efficacy. It is used to design adherence and screening interventions.
- Transtheoretical model stages
- The stages are precontemplation, contemplation, preparation, action and maintenance. Behaviour change is staged, and interventions are matched to the patient's current stage.
- Number needed to treat
- NNT = 1 ÷ absolute risk reduction, where ARR = control event rate − treatment event rate. It is the number of patients treated to prevent one additional adverse event.
- Incremental cost-effectiveness ratio
- ICER = (cost of intervention − cost of comparator) ÷ (effect of intervention − effect of comparator). It expresses the extra cost per additional unit of health outcome.
- Cost-utility analysis
- Cost-utility analysis measures outcomes in quality-adjusted life-years (QALYs), combining length and quality of life. Results are reported as cost per QALY gained.
- Sensitivity and specificity
- Sensitivity = TP ÷ (TP + FN) and measures true-positive detection. Specificity = TN ÷ (TN + FP) and measures true-negative detection. Both are independent of disease prevalence.
- Proportion of days covered
- PDC = days of medication supplied ÷ days in the observation period. A PDC of 0.80 or more is commonly used to define adherence when analysing pharmacy refill records.
- Evidence hierarchy
- Systematic reviews and meta-analyses of randomized trials rank highest, followed by randomized trials, cohort studies, case-control studies, case series and expert opinion.